Buspirone Hydrochloride Tablet
Product Images NDC 51407-417

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 51407-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-414-01ol.jpg (51407 413 01lb)

Buspirone Hydrochloride 5 mg tablets label displaying the product name, strength, dosage form, and quantity of 100 tablets. The label includes NDC 51407-413-01, manufacturer Strides Pharma Science Ltd., and marketer GSMS, Incorporated. It provides storage instructions, dosage reference, and safety warnings including child-resistant container and keeping medication out of reach of children.*

FDA Label Image

51407-414-01ol.jpg (51407 414 01ol)

Buspirone Hydrochloride 7.5 mg Tablets, USP label for oral use shows a 100-tablet bottle marketed by GSMS Incorporated. The label includes NDC 51407-414-01, pharmacist dispensing instructions, storage temperature, and manufacturer information from Strides Pharma Science Ltd. It emphasizes safe medication storage and child-resistant packaging.*

FDA Label Image

51407-415-01lb.jpg (51407 415 01lb)

Label for Buspirone Hydrochloride Tablets USP 10 mg, oral tablets, with a package size of 100 tablets. The label includes the NDC 51407-415-01, highlights the active ingredient strength as 10 mg, and contains instructions for pharmacists and storage conditions. Marketed by GSMS, Incorporated, Camarillo, CA, and manufactured by Strides Pharma Science Ltd.*

FDA Label Image

51407-416-05lb.jpg (51407 416 05lb)

Buspirone Hydrochloride 15 mg tablets label for oral use, displaying the product name prominently with strength in a green box. The label includes NDC 51407-416-05, package size of 500 tablets, and instructions for pharmacists to dispense patient information. Manufactured by Strides Pharma Science Ltd. and marketed by GSMS, Incorporated. Additional storage and dispensing instructions are noted.*

FDA Label Image

51407-417-60lb.jpg (51407 417 60lb)

Label for Buspirone Hydrochloride Tablets USP 30 mg from Golden State Medical Supply, Inc. The label shows the NDC 51407-417-60 and indicates a package of 60 tablets. It includes a barcode, storage instructions, and a pharmacist note for patient information dispensing. The label states the product is Rx only and was last revised in May 2022.*

FDA Label Image

Structure (B0825ce2 82b8 4850 9e90 4259728823b5 01)

Chemical structure of buspirone hydrochloride showing its molecular arrangement with a cyclohexane dione moiety linked to a piperazine ring and a pyrimidine ring, associated with hydrochloride.*

FDA Label Image

5mg-dosage Adjustment (B0825ce2 82b8 4850 9e90 4259728823b5 02)

An instructional diagram explaining tablet division for Buspirone Hydrochloride 15 mg oral tablets. It shows how to split the 15 mg tablet into parts to achieve 10 mg (two-thirds of a tablet), 7.5 mg (half a tablet), and 5 mg (one-third of a tablet) doses, with visual representations of tablet segments labeled by numbers.*

FDA Label Image

B0825ce2-82b8-4850-9e90-4259728823b5-03.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 03)

An instructional diagram showing two hands holding a tablet between the fingers, demonstrating how to handle or possibly split the tablet. The image is a line drawing without text or labels.*

FDA Label Image

B0825ce2-82b8-4850-9e90-4259728823b5-04.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 04)

An instructional diagram showing how to dose a 30 mg Buspirone Hydrochloride tablet by breaking it into smaller portions. It uses visual blocks representing the 30 mg tablet divided to illustrate dosages of 30 mg (whole tablet), 20 mg (two-thirds of the tablet), 15 mg (half a tablet), and 10 mg (one-third of the tablet).*

FDA Label Image

B0825ce2-82b8-4850-9e90-4259728823b5-05.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 05)

An instructional line drawing illustration showing two hands holding a thin, rectangular object, likely a tablet, between the thumb and forefinger of each hand. The image demonstrates how to hold the tablet carefully by its edges, possibly for inspection or administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.